PP
SUPN icon

Paloma Partners’s Supernus Pharmaceuticals SUPN Stock Holding History

Paloma Partners’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,632
Closed -$226K – 2253
2021
Q1 		$226K Buy
+8,632
New +$241K ﹤0.01% 1683
2020
Q4 		– Sell
-12,679
Closed -$264K – 2195
2020
Q3 		$264K Buy
12,679
+2,309
+22% +$52.4K 0.01% 1574
2020
Q2 		$247K Buy
+10,370
New +$229K ﹤0.01% 1576
2019
Q1 		– Sell
-7,230
Closed -$240K – 1932
2018
Q4 		$240K Buy
+7,230
New +$311K 0.01% 968
2018
Q2 		– Sell
-25,193
Closed -$1.15M – 2167
2018
Q1 		$1.15M Buy
25,193
+5,681
+29% +$237K 0.02% 908
2017
Q4 		$778K Sell
19,512
-19,142
-50% -$756K 0.01% 1155
2017
Q3 		$1.55M Buy
38,654
+4,012
+12% +$174K 0.02% 906
2017
Q2 		$1.49M Sell
34,642
-2,626
-7% -$93.5K 0.02% 955
2017
Q1 		$1.17M Sell
37,268
-11,920
-24% -$319K 0.01% 1145
2016
Q4 		$1.24M Buy
+49,188
New +$1.1M 0.01% 1031
2016
Q3 		– Sell
-14,948
Closed -$305K – 2118
2016
Q2 		$305K Buy
+14,948
New +$265K ﹤0.01% 1758
2016
Q1 		– Sell
-17,921
Closed -$241K – 2059
2015
Q4 		$241K Buy
+17,921
New +$277K 0.01% 1461
2014
Q4 		– Sell
-16,021
Closed -$139K – 1352
2014
Q3 		$139K Buy
+16,021
New +$145K 0.01% 875

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Paloma Partners's SUPN Position: Q2 2021 in Review

Paloma Partners sold out of Supernus Pharmaceuticals (SUPN) in Q2 2021, closing a stake of 8,632 shares — an estimated $226K sold.

Paloma Partners first reported a position in SUPN in Q3 2014 and held it in 13 quarters. The position peaked at $1.55M in Q3 2017. 226 funds tracked by Wall St. Rank hold SUPN as of Q2 2021.

  • Paloma Partners reported no remaining Supernus Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Paloma Partners sold 8,632 Supernus Pharmaceuticals shares in Q2 2021, an estimated $226K.
  • Paloma Partners first reported a position in Supernus Pharmaceuticals in Q3 2014 and held it in 13 quarters.
  • Paloma Partners's Supernus Pharmaceuticals position peaked at $1.55M in Q3 2017.
  • 226 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2021.

Based on Paloma Partners's 13F filing for Q2 2021, filed 16 Aug 2021.